Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-19 Sale |
2025-03-21 5:49 pm |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
12,500 | $20.61 | $257,575 | 1,002,688 (Indirect) |
View |
| 2024-10-18 Sale |
2024-10-22 4:22 pm |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
847 | $30 | $25,413 | 1,015,188 (Indirect) |
View |
| 2024-10-08 Sale |
2024-10-10 8:39 pm |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
51,145 | $28.11 | $1,437,585 | 1,016,035 (Indirect) |
View |
| 2024-10-04 Sale |
2024-10-08 6:58 pm |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
10,229 | $27.54 | $281,664 | 1,067,180 (Indirect) |
View |
| 2024-10-01 Sale |
2024-10-03 6:47 pm |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
527 | $27.54 | $14,512 | 1,077,409 (Indirect) |
View |
| 2024-08-29 Sale |
2024-09-03 5:43 pm |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
12,000 | $22.49 | $269,841 | 1,077,936 (Indirect) |
View |
| 2024-07-31 Sale |
2024-08-02 7:26 pm |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
3,099 | $27.56 | $85,399 | 1,089,936 (Indirect) |
View |
| 2024-07-29 Sale |
2024-07-31 7:33 pm |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
12,000 | $26.7 | $320,378 | 1,093,035 (Indirect) |
View |
| 2024-07-01 Sale |
2024-07-03 4:31 pm |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
12,000 | $22.89 | $274,736 | 1,105,035 (Indirect) |
View |
| 2024-05-29 Sale |
2024-05-31 4:05 pm |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
12,000 | $21.73 | $260,800 | 1,323,585 (Indirect Direct) |
View |
| 2024-04-29 Sale |
2024-05-01 7:04 pm |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
12,000 | $17.92 | $214,988 | 1,335,585 (Indirect Direct) |
View |
| 2024-04-11 Sale |
2024-04-15 7:06 pm |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
30,000 | $25.04 | $751,332 | 1,347,585 (Indirect Direct) |
View |
| 2024-04-01 Sale |
2024-04-03 9:30 pm |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
12,000 | $18.6 | $223,146 | 1,377,585 (Indirect Direct) |
View |
| 2024-02-29 Sale |
2024-03-04 5:55 pm |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
12,000 | $16.42 | $197,006 | 1,389,585 (Indirect Direct) |
View |
| 2024-01-29 Sale |
2024-01-31 9:22 pm |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
12,000 | $15.85 | $190,256 | 1,401,585 (Indirect Direct) |
View |
| 2023-12-29 Sale |
2024-01-03 7:01 pm |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P Chief Scientific Officer |
12,000 | $14.28 | $171,381 | 1,413,585 (Indirect Direct) |
View |
| 2023-12-21 Sale |
2023-12-26 7:32 pm |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P Chief Scientific Officer |
6,566 | $13.07 | $85,790 | 1,740,681 (Indirect Direct) |
View |
| 2023-12-19 Sale |
2023-12-21 4:29 pm |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P Chief Scientific Officer |
8,888 | $13.01 | $115,646 | 1,755,955 (Indirect Direct) |
View |
| 2023-11-03 Sale |
2023-11-06 4:43 pm |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P Chief Scientific Officer |
8,546 | $13.08 | $111,751 | 1,441,039 (Indirect Direct) |
View |
| 2023-09-29 Sale |
2023-10-03 7:40 pm |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P Chief Scientific Officer |
12,000 | $13.62 | $163,498 | 1,449,585 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-06 Option Award |
2025-02-10 5:29 pm |
N/A 2035-02-06 |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
171,000 | $0 | 171,000 (Direct) |
View |
| 2024-05-29 Exercise |
2024-05-31 4:05 pm |
N/A 2030-06-16 |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
12,000 | $0 | 1,323,585 (Direct) |
View |
| 2024-05-29 Exercise |
2024-05-31 4:05 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
12,000 | $1.12 | 1,323,585 (Direct) |
View |
| 2024-04-29 Exercise |
2024-05-01 7:04 pm |
N/A 2030-06-16 |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
12,000 | $0 | 1,335,585 (Direct) |
View |
| 2024-04-29 Exercise |
2024-05-01 7:04 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
12,000 | $1.12 | 1,335,585 (Direct) |
View |
| 2024-04-11 Exercise |
2024-04-15 7:06 pm |
N/A 2030-06-16 |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
30,000 | $0 | 1,347,585 (Direct) |
View |
| 2024-04-11 Exercise |
2024-04-15 7:06 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
30,000 | $1.12 | 1,347,585 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 9:30 pm |
N/A 2030-06-16 |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
12,000 | $0 | 1,377,585 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 9:30 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
12,000 | $1.12 | 1,377,585 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-04 5:55 pm |
N/A 2030-06-15 |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
12,000 | $0 | 1,389,585 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-04 5:55 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
12,000 | $1.12 | 1,389,585 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 9:00 pm |
N/A 2034-02-12 |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
185,000 | $0 | 185,000 (Direct) |
View |
| 2024-01-29 Exercise |
2024-01-31 9:22 pm |
N/A 2030-06-15 |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
12,000 | $0 | 1,401,585 (Direct) |
View |
| 2024-01-29 Exercise |
2024-01-31 9:22 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
12,000 | $1.12 | 1,401,585 (Direct) |
View |
| 2023-12-29 Exercise |
2024-01-03 7:01 pm |
N/A 2030-06-15 |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P Chief Scientific Officer |
12,000 | $0 | 1,413,585 (Direct) |
View |
| 2023-12-29 Exercise |
2024-01-03 7:01 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P Chief Scientific Officer |
12,000 | $1.12 | 1,413,585 (Direct) |
View |
| 2023-12-21 Exercise |
2023-12-26 7:32 pm |
N/A 2030-06-15 |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P Chief Scientific Officer |
6,566 | $0 | 1,740,681 (Direct) |
View |
| 2023-12-21 Exercise |
2023-12-26 7:32 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P Chief Scientific Officer |
6,566 | $1.12 | 1,740,681 (Direct) |
View |
| 2023-12-19 Exercise |
2023-12-21 4:29 pm |
N/A 2030-06-15 |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P Chief Scientific Officer |
8,888 | $0 | 1,755,955 (Direct) |
View |
| 2023-12-19 Exercise |
2023-12-21 4:29 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P Chief Scientific Officer |
8,888 | $1.12 | 1,755,955 (Direct) |
View |
| 2023-11-03 Exercise |
2023-11-06 4:43 pm |
N/A 2030-06-15 |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P Chief Scientific Officer |
8,546 | $0 | 1,441,039 (Direct) |
View |
| 2023-11-03 Exercise |
2023-11-06 4:43 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P Chief Scientific Officer |
8,546 | $1.12 | 1,441,039 (Direct) |
View |
| 2023-09-29 Exercise |
2023-10-03 7:40 pm |
N/A 2030-06-15 |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P Chief Scientific Officer |
12,000 | $0 | 1,449,585 (Direct) |
View |
| 2023-09-29 Exercise |
2023-10-03 7:40 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P Chief Scientific Officer |
12,000 | $1.12 | 1,449,585 (Direct) |
View |
| 2023-04-04 Option Award |
2023-04-06 8:33 pm |
N/A 2033-04-04 |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P Chief Scientific Officer |
206,000 | $0 | 206,000 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 9:34 pm |
N/A 2030-06-15 |
Enliven Therapeutics Inc. | ELVN | Lyssikatos Joseph P Chief Scientific Officer |
1,550,116 | $0 | 1,550,116 (Direct) |
View |